Mocikat R - Search Results

1

Epstein-Barr virus vector-mediated gene transfer into human B cells: potential for antitumor vaccination.

Hellebrand E, Mautner J, Reisbach G, Nimmerjahn F, Hallek M, Mocikat R, Hammerschmidt W. Hellebrand E, et al. Among authors: mocikat r. Gene Ther. 2006 Jan;13(2):150-62. doi: 10.1038/sj.gt.3302602. Gene Ther. 2006. PMID: 16136164

2

Induction of tumor immunity by autologous B lymphoma cells expressing a genetically engineered idiotype.

Selmayr M, Strehl J, Kremer JP, Kremmer E, Doenecke A, Hallek M, Menzel H, Thielemans K, Thierfelder S, Mocikat R. Selmayr M, et al. Among authors: mocikat r. Gene Ther. 1999 May;6(5):778-84. doi: 10.1038/sj.gt.3300875. Gene Ther. 1999. PMID: 10505101

3

Vaccination against B-cell chronic lymphocytic leukemia with trioma cells: preclinical evaluation.

Wahl U, Nössner E, Kronenberger K, Gangnus R, Pohla H, Staege MS, Kolb HJ, Hallek M, Mocikat R. Wahl U, et al. Among authors: mocikat r. Clin Cancer Res. 2003 Sep 15;9(11):4240-6. Clin Cancer Res. 2003. PMID: 14519651

4

EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells--a new option for the treatment of B-CLL.

Ruiss R, Jochum S, Mocikat R, Hammerschmidt W, Zeidler R. Ruiss R, et al. Among authors: mocikat r. PLoS One. 2011;6(10):e25294. doi: 10.1371/journal.pone.0025294. Epub 2011 Oct 10. PLoS One. 2011. PMID: 22022385 Free PMC article.

5

Dendritic cell-based immunogens for B-cell chronic lymphocytic leukemia.

Allgeier T, Garhammer S, Nössner E, Wahl U, Kronenberger K, Dreyling M, Hallek M, Mocikat R. Allgeier T, et al. Among authors: mocikat r. Cancer Lett. 2007 Jan 8;245(1-2):275-83. doi: 10.1016/j.canlet.2006.01.019. Epub 2006 Mar 3. Cancer Lett. 2007. PMID: 16516377

6

B-cell lymphoma idiotypes chimerized by gene targeting can induce tumor immunity.

Selmayr M, Menzel H, Kremer JP, Thierfelder S, Mocikat R. Selmayr M, et al. Among authors: mocikat r. Cancer Gene Ther. 2000 Mar;7(3):501-6. doi: 10.1038/sj.cgt.7700129. Cancer Gene Ther. 2000. PMID: 10766357

7

A polyvalent cellular vaccine induces T-cell responses against specific self-antigens overexpressed in chronic lymphocytic B-cell leukemia.

Kronenberger K, Nössner E, Frankenberger B, Wahl U, Dreyling M, Hallek M, Mocikat R. Kronenberger K, et al. Among authors: mocikat r. J Immunother. 2008 Oct;31(8):723-30. doi: 10.1097/CJI.0b013e318183af26. J Immunother. 2008. PMID: 18779747

8

Gene therapy of B-cell lymphoma with cytokine gene-modified trioma cells.

Strehl J, Selmayr M, Kremer JP, Hültner L, Lindhofer H, Mocikat R. Strehl J, et al. Among authors: mocikat r. Int J Cancer. 1999 Sep 24;83(1):113-20. doi: 10.1002/(sici)1097-0215(19990924)83:1<113::aid-ijc20>3.0.co;2-j. Int J Cancer. 1999. PMID: 10449617

9

Impact of the lymphoma idiotype on in vivo tumor protection in a vaccination model based on targeting antigens to antigen-presenting cells.

Kronenberger K, Dieckmann A, Selmayr M, Strehl J, Wahl U, Lindhofer H, Kraal G, Mocikat R. Kronenberger K, et al. Among authors: mocikat r. Blood. 2002 Feb 15;99(4):1327-31. doi: 10.1182/blood.v99.4.1327. Blood. 2002. PMID: 11830483 Free article.

10

Specific targeting of whole lymphoma cells to dendritic cells ex vivo provides a potent antitumor vaccine.

Adam C, Mysliwietz J, Mocikat R. Adam C, et al. Among authors: mocikat r. J Transl Med. 2007 Mar 14;5:16. doi: 10.1186/1479-5876-5-16. J Transl Med. 2007. PMID: 17359532 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

64 results

Search Page

Filters